블로그
- FDA] FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device For Immediate Release August 19, 2026 The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood
- [Philippines FDA] FDA Advisory No.2026-0879 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0879 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic of 03 August 2026.
- [Philippines FDA] FDA Advisory No.2026-0878 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0878 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product Notification (CPN) as of 03 .......
- [Philippines FDA] FDA Advisory No.2026-0854 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0854 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic (CPN) as of 23 June 2026.
- [Philippines FDA] FDA Advisory No.2026-0853 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0853 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic of 23 June 2026.
- [Philippines FDA] FDA Advisory No.2026-0851 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0851 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic (CPN) as of 23 June 2026.
- [Philippines FDA] FDA Advisory No.2026-0850 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0850 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product Notification (CPN) as of 23 June 2.......
- [Philippines FDA] FDA Advisory No.2026-0863 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0863 || Public Health Warning Against the Purchase and Use of the Unregistered Drug use of the following unregistered drug product: 1.
- [Philippines FDA] FDA Advisory No.2026-0862 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0862 || Public Health Warning Against the Purchase and Use of the Unregistered Drug ) advises the public against the purchase and use of the following unregistered drug product: 1.
- [Philippines FDA] FDA Advisory No.2026-0861 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0861 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Certificate of Product Registration (CPR).
동영상
뉴스
- 컨티뉴이티 바이오사이언시스, 신임 이사회 멤버에 비키 파푸치스 Torrente): 미국의 대표적 FDA 전문 로펌 하이먼 펠프스 앤드 맥나마라(Hyman, Phelps & McNamara, P.C.)의 전 파트너다. TIME이 선정한 '2026년 가장 영향력 있는 보건·생명과학 기업 10곳(10 Most Influential Health and Life Sciences Companies of
- 국산 비만치료제, 해외서 긍정적 임상평가 발표했다.메타비아 최고 의학책임자(CMO)인 크리스 팡(Chris Fang)은 ‘Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 또 미국 식품의약국(FDA)으로부터 만성 체중관리 적응증에 대한 임상 2상 시험계획을 승인받았으며, 현재 미국에서 과체중 또는 비만 환자를 대상으로 위약, 터제파타이드와 직접 비교하는